뒤로
Acura Pharmaceuticals Inc (ACUR) 수입
ACUR 주가 차트
ACUR 수입
Acura Pharmaceuticals Inc
$0.01
0%
$0
종가: Mar 27, 16:00:00 GMT-4
$0.01
0%
$0
애프터마켓: Mar 27, 20:00:00 GMT-4
Earnings FAQ
ACUR의 최근 주당순이익(EPS)은 예상과 비교하여 어떤가요?
Acura Pharmaceuticals Inc ACUR의 지난 분기 매출 실적은 어땠나요?
Acura Pharmaceuticals Inc의 매출 추정치는 얼마인가요?
Acura Pharmaceuticals Inc의 수익 품질 점수는 얼마인가요?
Acura Pharmaceuticals Inc는 언제 수익을 보고하나요?
Acura Pharmaceuticals Inc의 예상 수익은 얼마인가요?
Acura Pharmaceuticals Inc은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$0.01
시가
$0.0004
일일 범위
$0.0004 - $0.01
52주 범위
$0.0001 - $0.02
거래량
400
평균 거래량
516
배당수익률
--
EPS(TTM)
-0.02
시가총액
$663.4K
ACUR란 무엇인가요?
Acura Pharmaceuticals, Inc. is a drug delivery company, which engages in the research, development, and commercialization of technologies and products intended to address safe use of medications. The company is headquartered in Palatine, Illinois. The company went IPO on 2000-09-12. Its platform technologies include LIMITX Technology, AVERSION Technology, and IMPEDE Technology. Its LIMITX Technology is designed to minimize the risks and side effects associated with overdose by retarding the release of active drug ingredients when too many tablets are accidentally or purposefully ingested. The LIMITX Technology is in development with hydrocodone bitartrate and acetaminophen (also known as LTX-03) as the lead product candidates. Its AVERSION Technology is to address methods of product tampering associated with opioid abuse by incorporating gelling ingredients and irritants into tablets to discourage abuse by snorting and provide barriers to abuse by injection. Its IMPEDE Technology is directed at minimizing the extraction and conversion of pseudoephedrine tablets into methamphetamine.